US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 93.000
  • +2.270+2.50%
Close Apr 26 16:00 ET
  • 94.990
  • +1.990+2.14%
Post 19:13 ET
5.84BMarket Cap-11111P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.03%-436.85M
34.99%-78.93M
19.56%-104.48M
-10.33%-130.48M
7.36%-122.96M
-68.18%-502.28M
-760.17%-121.41M
-35.87%-129.89M
-87.22%-118.26M
-5.52%-132.73M
Net income from continuing operations
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
-47.27%-159.71M
-6.30%-106M
Depreciation and amortization
-0.60%11.67M
-78.18%1.53M
77.17%2.87M
143.40%3.58M
126.29%3.68M
81.12%11.74M
321.89%7.02M
0.31%1.62M
-7.66%1.47M
1.24%1.63M
Other non cash items
3,511.75%24.39M
-72.17%3.41M
167.25%11.84M
66.19%3M
115.44%6.14M
-100.27%-715K
-95.33%12.24M
-703.18%-17.61M
-23.66%1.81M
38.48%2.85M
Change In working capital
23.51%-41.13M
264.99%10.4M
152.24%2.97M
-318.89%-28.08M
51.61%-26.42M
-127.07%-53.77M
-138.06%-6.31M
16.95%-5.69M
-24.59%12.83M
-8.31%-54.6M
-Change in receivables
-242.92%-7.65M
90.02%-1.7M
-142.55%-3.14M
-352.65%-7.76M
12.76%4.95M
81.09%-2.23M
-133.12%-17.07M
-22.21%7.37M
-33.76%3.07M
123.60%4.39M
-Change in inventory
51.06%-4.37M
-92.93%829K
148.95%2.92M
-68.31%-8.19M
100.79%78K
28.97%-8.92M
1,666.22%11.73M
18.03%-5.96M
-1,749.49%-4.87M
-103.18%-9.83M
-Change in prepaid assets
118.93%3.21M
514.89%5.66M
-658.46%-4.13M
-224.10%-4.06M
129.31%5.74M
-460.92%-16.94M
-121.01%-1.36M
171.06%739K
78.03%3.27M
-655.13%-19.59M
-Change in payables and accrued expense
-16.81%2.96M
713.82%13.81M
964.82%10.62M
-138.43%-5.6M
-110.81%-15.88M
-65.57%3.55M
-112.49%-2.25M
70.14%-1.23M
-24.10%14.56M
66.93%-7.53M
-Change in other current assets
71.13%-4.71M
32.63%-2.99M
-123.43%-305K
-281.19%-1M
96.97%-417K
-813.77%-16.32M
-519.89%-4.43M
31.91%1.3M
114.61%553K
-31,129.55%-13.74M
-Change in other current liabilities
-120.74%-17.87M
65.34%-2.79M
-11.58%-2.68M
-0.93%-2.6M
-297.98%-9.79M
-1.77%-8.1M
-284.09%-8.06M
-19.39%-2.4M
-4.58%-2.58M
459.00%4.95M
-Change in other working capital
-163.60%-12.69M
-115.90%-2.41M
94.25%-317K
195.70%1.14M
16.24%-11.1M
-5.04%-4.81M
1,184.05%15.14M
-91.39%-5.51M
55.96%-1.19M
-7,062.70%-13.25M
Cash from discontinued investing activities
Operating cash flow
13.03%-436.85M
34.99%-78.93M
19.56%-104.48M
-10.33%-130.48M
7.36%-122.96M
-68.18%-502.28M
-760.17%-121.41M
-35.87%-129.89M
-87.22%-118.26M
-5.52%-132.73M
Investing cash flow
Cash flow from continuing investing activities
283.25%274.04M
247.83%78.77M
92.75%-9.59M
-58.39%32.07M
520.52%172.79M
33.79%-149.54M
84.64%-53.28M
-227.06%-132.24M
166.91%77.07M
-131.08%-41.09M
Net PPE purchase and sale
-80.09%-16.06M
-215.53%-4.67M
-67.63%-6.25M
0.08%-2.55M
-124.11%-2.58M
-188.73%-8.92M
-17.73%-1.48M
-274.40%-3.73M
-286.10%-2.56M
-566.47%-1.15M
Net intangibles purchase and sale
--0
----
----
----
----
--0
----
----
----
----
Net investment purchase and sale
306.73%290.1M
261.08%83.44M
97.40%-3.34M
-56.52%34.62M
539.13%175.38M
-496.63%-140.33M
40.83%-51.8M
-222.03%-128.22M
169.53%79.62M
-130.17%-39.94M
Net other investing changes
----
----
----
----
----
---290K
---1K
----
----
----
Cash from discontinued investing activities
Investing cash flow
283.25%274.04M
247.83%78.77M
92.75%-9.59M
-58.39%32.07M
520.52%172.79M
33.79%-149.54M
84.64%-53.28M
-227.06%-132.24M
166.91%77.07M
-131.08%-41.09M
Financing cash flow
Cash flow from continuing financing activities
-78.78%119.23M
523.36%15.53M
-74.14%98.4M
-97.02%5.3M
0
1,007.76%561.81M
-86.11%2.49M
3,384.32%380.56M
1,094.95%177.5M
-81.97%1.26M
Net issuance payments of debt
-28.92%97.93M
-218.18%-35K
----
----
----
--137.79M
---11K
----
----
----
Proceeds from stock option exercised by employees
160.32%21.34M
521.79%15.61M
-77.60%431K
112.09%5.3M
--0
-83.84%8.2M
-86.00%2.51M
-82.38%1.92M
-83.18%2.5M
-81.97%1.26M
Net other financing activities
-100.01%-44K
----
----
----
----
--415.83M
---8K
--240.84M
----
----
Cash from discontinued financing activities
Financing cash flow
-78.78%119.23M
523.36%15.53M
-74.14%98.4M
-97.02%5.3M
--0
1,007.76%561.81M
-86.11%2.49M
3,384.32%380.56M
1,094.95%177.5M
-81.97%1.26M
Net cash flow
Beginning cash position
-41.94%124.9M
-77.86%65.67M
-54.15%81.88M
312.87%174.93M
-41.94%124.9M
-68.81%215.12M
-46.91%296.62M
-66.90%178.57M
-93.97%42.37M
-68.81%215.12M
Current changes in cash
51.58%-43.58M
108.93%15.37M
-113.23%-15.67M
-168.31%-93.11M
128.88%49.83M
81.00%-90.01M
49.82%-172.2M
510.51%118.43M
183.38%136.31M
-1,384.83%-172.55M
Effect of exchange rate changes
197.58%202K
1.88%487K
-42.74%-541K
154.13%59K
200.00%197K
76.69%-207K
194.47%478K
-208.13%-379K
32.72%-109K
-103.09%-197K
End cash Position
-34.73%81.52M
-34.73%81.52M
-77.86%65.67M
-54.15%81.88M
312.87%174.93M
-41.94%124.9M
-41.94%124.9M
-46.91%296.62M
-66.90%178.57M
-93.97%42.37M
Free cash flow
11.40%-452.91M
31.97%-83.6M
17.13%-110.73M
-10.11%-133.03M
6.23%-125.55M
8.70%-511.2M
55.07%-122.89M
-38.33%-133.62M
-89.28%-120.81M
-6.29%-133.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.03%-436.85M34.99%-78.93M19.56%-104.48M-10.33%-130.48M7.36%-122.96M-68.18%-502.28M-760.17%-121.41M-35.87%-129.89M-87.22%-118.26M-5.52%-132.73M
Net income from continuing operations 9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M-47.27%-159.71M-6.30%-106M
Depreciation and amortization -0.60%11.67M-78.18%1.53M77.17%2.87M143.40%3.58M126.29%3.68M81.12%11.74M321.89%7.02M0.31%1.62M-7.66%1.47M1.24%1.63M
Other non cash items 3,511.75%24.39M-72.17%3.41M167.25%11.84M66.19%3M115.44%6.14M-100.27%-715K-95.33%12.24M-703.18%-17.61M-23.66%1.81M38.48%2.85M
Change In working capital 23.51%-41.13M264.99%10.4M152.24%2.97M-318.89%-28.08M51.61%-26.42M-127.07%-53.77M-138.06%-6.31M16.95%-5.69M-24.59%12.83M-8.31%-54.6M
-Change in receivables -242.92%-7.65M90.02%-1.7M-142.55%-3.14M-352.65%-7.76M12.76%4.95M81.09%-2.23M-133.12%-17.07M-22.21%7.37M-33.76%3.07M123.60%4.39M
-Change in inventory 51.06%-4.37M-92.93%829K148.95%2.92M-68.31%-8.19M100.79%78K28.97%-8.92M1,666.22%11.73M18.03%-5.96M-1,749.49%-4.87M-103.18%-9.83M
-Change in prepaid assets 118.93%3.21M514.89%5.66M-658.46%-4.13M-224.10%-4.06M129.31%5.74M-460.92%-16.94M-121.01%-1.36M171.06%739K78.03%3.27M-655.13%-19.59M
-Change in payables and accrued expense -16.81%2.96M713.82%13.81M964.82%10.62M-138.43%-5.6M-110.81%-15.88M-65.57%3.55M-112.49%-2.25M70.14%-1.23M-24.10%14.56M66.93%-7.53M
-Change in other current assets 71.13%-4.71M32.63%-2.99M-123.43%-305K-281.19%-1M96.97%-417K-813.77%-16.32M-519.89%-4.43M31.91%1.3M114.61%553K-31,129.55%-13.74M
-Change in other current liabilities -120.74%-17.87M65.34%-2.79M-11.58%-2.68M-0.93%-2.6M-297.98%-9.79M-1.77%-8.1M-284.09%-8.06M-19.39%-2.4M-4.58%-2.58M459.00%4.95M
-Change in other working capital -163.60%-12.69M-115.90%-2.41M94.25%-317K195.70%1.14M16.24%-11.1M-5.04%-4.81M1,184.05%15.14M-91.39%-5.51M55.96%-1.19M-7,062.70%-13.25M
Cash from discontinued investing activities
Operating cash flow 13.03%-436.85M34.99%-78.93M19.56%-104.48M-10.33%-130.48M7.36%-122.96M-68.18%-502.28M-760.17%-121.41M-35.87%-129.89M-87.22%-118.26M-5.52%-132.73M
Investing cash flow
Cash flow from continuing investing activities 283.25%274.04M247.83%78.77M92.75%-9.59M-58.39%32.07M520.52%172.79M33.79%-149.54M84.64%-53.28M-227.06%-132.24M166.91%77.07M-131.08%-41.09M
Net PPE purchase and sale -80.09%-16.06M-215.53%-4.67M-67.63%-6.25M0.08%-2.55M-124.11%-2.58M-188.73%-8.92M-17.73%-1.48M-274.40%-3.73M-286.10%-2.56M-566.47%-1.15M
Net intangibles purchase and sale --0------------------0----------------
Net investment purchase and sale 306.73%290.1M261.08%83.44M97.40%-3.34M-56.52%34.62M539.13%175.38M-496.63%-140.33M40.83%-51.8M-222.03%-128.22M169.53%79.62M-130.17%-39.94M
Net other investing changes -----------------------290K---1K------------
Cash from discontinued investing activities
Investing cash flow 283.25%274.04M247.83%78.77M92.75%-9.59M-58.39%32.07M520.52%172.79M33.79%-149.54M84.64%-53.28M-227.06%-132.24M166.91%77.07M-131.08%-41.09M
Financing cash flow
Cash flow from continuing financing activities -78.78%119.23M523.36%15.53M-74.14%98.4M-97.02%5.3M01,007.76%561.81M-86.11%2.49M3,384.32%380.56M1,094.95%177.5M-81.97%1.26M
Net issuance payments of debt -28.92%97.93M-218.18%-35K--------------137.79M---11K------------
Proceeds from stock option exercised by employees 160.32%21.34M521.79%15.61M-77.60%431K112.09%5.3M--0-83.84%8.2M-86.00%2.51M-82.38%1.92M-83.18%2.5M-81.97%1.26M
Net other financing activities -100.01%-44K------------------415.83M---8K--240.84M--------
Cash from discontinued financing activities
Financing cash flow -78.78%119.23M523.36%15.53M-74.14%98.4M-97.02%5.3M--01,007.76%561.81M-86.11%2.49M3,384.32%380.56M1,094.95%177.5M-81.97%1.26M
Net cash flow
Beginning cash position -41.94%124.9M-77.86%65.67M-54.15%81.88M312.87%174.93M-41.94%124.9M-68.81%215.12M-46.91%296.62M-66.90%178.57M-93.97%42.37M-68.81%215.12M
Current changes in cash 51.58%-43.58M108.93%15.37M-113.23%-15.67M-168.31%-93.11M128.88%49.83M81.00%-90.01M49.82%-172.2M510.51%118.43M183.38%136.31M-1,384.83%-172.55M
Effect of exchange rate changes 197.58%202K1.88%487K-42.74%-541K154.13%59K200.00%197K76.69%-207K194.47%478K-208.13%-379K32.72%-109K-103.09%-197K
End cash Position -34.73%81.52M-34.73%81.52M-77.86%65.67M-54.15%81.88M312.87%174.93M-41.94%124.9M-41.94%124.9M-46.91%296.62M-66.90%178.57M-93.97%42.37M
Free cash flow 11.40%-452.91M31.97%-83.6M17.13%-110.73M-10.11%-133.03M6.23%-125.55M8.70%-511.2M55.07%-122.89M-38.33%-133.62M-89.28%-120.81M-6.29%-133.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday+0.03%